O-021 Tailored strategy for locally-advanced rectal carcinoma: preliminary results of a phase II multicenter trial (GRECCAR 4)

MLA

B. Lelong, et al. “O-021 Tailored Strategy for Locally-Advanced Rectal Carcinoma: Preliminary Results of a Phase II Multicenter Trial (GRECCAR 4).” Annals of Oncology, vol. 27, June 2016, p. ii126. EBSCOhost, https://doi.org/10.1093/annonc/mdw198.21.

APA

B. Lelong, Sophie Gourgou, M. Ychou, C. Lemanski, Denis Pezet, Stephanie Nougaret, Eric Rullier, B. Meunier, j. Tuech Jean, Philippe Rouanet, Florence Castan, Michel Rivoire, & Philippe Maingon. (2016). O-021 Tailored strategy for locally-advanced rectal carcinoma: preliminary results of a phase II multicenter trial (GRECCAR 4). Annals of Oncology, 27, ii126. https://doi.org/10.1093/annonc/mdw198.21

Chicago

B. Lelong, Sophie Gourgou, M. Ychou, C. Lemanski, Denis Pezet, Stephanie Nougaret, Eric Rullier, et al. 2016. “O-021 Tailored Strategy for Locally-Advanced Rectal Carcinoma: Preliminary Results of a Phase II Multicenter Trial (GRECCAR 4).” Annals of Oncology 27 (June): ii126. doi:10.1093/annonc/mdw198.21.